Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses

Chest. 2004 Jul;126(1):314-5; author reply 315-6. doi: 10.1378/chest.126.1.314.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Acetamides / therapeutic use*
  • Anti-Bacterial Agents / therapeutic use*
  • Anti-Infective Agents / therapeutic use*
  • Cross Infection / drug therapy*
  • Cross Infection / mortality
  • Humans
  • Linezolid
  • Methicillin Resistance*
  • Oxazolidinones / therapeutic use*
  • Pneumonia, Staphylococcal / drug therapy*
  • Pneumonia, Staphylococcal / mortality
  • Randomized Controlled Trials as Topic
  • Vancomycin / therapeutic use*

Substances

  • Acetamides
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Oxazolidinones
  • Vancomycin
  • Linezolid